Key statistics
On Wednesday, Resmed Inc (R1MD34:SAO) closed at 357.70, -6.12% below its 52-week high of 381.00, set on Nov 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 357.70 |
---|---|
High | 357.70 |
Low | 357.70 |
Bid | 348.60 |
Offer | 355.00 |
Previous close | 357.70 |
Average volume | 34.50 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 2.12 BRL |
---|---|
Annual div yield (ADY) | 0.59% |
Div ex-date | May 07 2025 |
Div pay-date | Jun 18 2025 |
Data delayed at least 15 minutes, as of Jun 25 2025 20:54 BST.
More ▼
Announcements
- Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025
- Resmed Acquires VirtuOx
- Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025
- Resmed Names Salli Schwartz as Chief Investor Relations Officer
- Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US
- Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025
- New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer
- Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
- ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep
- ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025
More ▼